|
Re: Wow…
|
1
|
Zenith Epigenetics
|
Sep 23, 2024 11:59AM
|
|
Re: Lu stepping down
|
1
|
Resverlogix Corp.
|
Apr 25, 2024 02:15PM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
1
|
Resverlogix Corp.
|
Oct 04, 2023 01:27PM
|
|
Re: Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Feb 23, 2023 02:56PM
|
|
Expert market
|
1
|
Zenith Epigenetics
|
Sep 18, 2024 02:09PM
|
|
Re: why on earth
|
1
|
Resverlogix Corp.
|
May 13, 2024 01:41PM
|
|
Re: why on earth
|
1
|
Resverlogix Corp.
|
May 13, 2024 02:43PM
|
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 29, 2024 12:25PM
|
|
Re: Novavax
|
1
|
Resverlogix Corp.
|
Mar 02, 2023 10:53AM
|
|
Possibility?
|
1
|
Resverlogix Corp.
|
May 07, 2024 09:30AM
|
|
Re: short interest up 60% from 230,476 to 369,578/OTC/market
|
1
|
Resverlogix Corp.
|
Apr 27, 2023 12:16PM
|
|
Re: Leak? SP up 51% !
|
1
|
Resverlogix Corp.
|
Apr 04, 2023 02:56PM
|
|
Re: Epigenetics market size
|
1
|
Zenith Epigenetics
|
Jan 22, 2024 02:46PM
|
|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jan 30, 2024 02:24PM
|
|
Phase 1B in TNBC suspended
|
1
|
Zenith Epigenetics
|
May 23, 2024 07:18PM
|
|
Re: Zenith Royalties
|
1
|
Resverlogix Corp.
|
Jun 22, 2023 02:14PM
|
|
Re: Zenith trial partners
|
1
|
Zenith Epigenetics
|
Feb 01, 2023 01:13PM
|
|
Re: What's the deal with Zenith?
|
|
Zenith Epigenetics
|
Jun 22, 2023 03:49PM
|
|
Re: OTC Expert & Grey Market Restrictions
|
|
Zenith Epigenetics
|
Nov 21, 2022 05:21PM
|
|
Re: OTC Expert & Grey Market Restrictions
|
|
Zenith Epigenetics
|
Nov 21, 2022 05:31PM
|
